We are thrilled to have our poster entitled “iPSC-derived hepatocytes revisited: improved liver functionality compared to liver cancer cell lines and a better model for pre-clinical large-scale therapeutic screening and drug safety”, selected for the “Hepatocyte biology” poster tour at the EASL Congress 2024 by the EASL Scientific Committee.
The poster tour is a dedicated session where discussions surrounding 4-6 selected posters, including DefiniGEN’s, will take place. The session is scheduled on Friday 7th June, 16:15 – 17:00 at the “Basic Science” track hub.
As well as seeing Nik present on the poster tour, meet Nik and our other Nick at booth D4 to learn how we can develop custom models for screening or characterizing lead compounds for liver indications that have previously been difficult to study.
